Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7033-7041

  Silveira, Pablo A ^b   Chapman, Harold D ^a   Stolp, Jessica ^b   Johnson, Elis ^a   Cox, S Lewis ^b   Hunter, Kara ^c   Wicker, Linda S ^c   Serreze, David V ^a  

^a JACKSON LABORATORY   (United States)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENE LOCUS; GENETIC SUSCEPTIBILITY; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 33750842649     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7033     Document Type: Article

References (51)

1. Fox, C. J., and J. S. Danska. 1998. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 47: 331-338.
2. Jarpe, A. J., M. R. Hickman, J. T. Anderson, W. E. Winter, and A. B. Peck. 1990. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg. Immunol. 3: 305-317.
3. Gottlieb, P. A., and G. S. Eisenbarth. 1998. Diagnosis and treatment of pre-insulin dependent diabetes. Annu. Rev. Med. 49: 391-405.
4. Noorchashm, H., N. Noorchashm, J. Kern, S. Y. Rostami, C. F. Barker, and A. Naji. 1997. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46: 941-946.
5. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S.D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shulte. 1996. B lymphocytes are essential for the initiation of T-cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J. Exp. Med. 184: 2049-2053.
6. Martin, S., D. Wolf-Eichbaum, G. Duinkerken, W. A. Scherbaum, H. Kolb, J. G. Noordzij, and B. O. Roep. 2001. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N. Engl. J. Med. 345: 1036-1040.
7. Greeley, S. A., M. Katsumata, L. Yu, G. S. Eisenbarth, D. J. Moore, H. Goodarzi, C. F. Barker, A. Naji, and H. Noorchashm. 2002. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8: 399-402.
8. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T-cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918.
9. Falcone, M., J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163-1168.
10. Noorchashm, H., Y. K. Lieu, N. Noorchashm, S. Y. Rostami, S. A. Greeley, A. Schlachterman, H. K. Song, L. E. Noto, A. M. Jevnikar, C. F. Barker, and A. Naji. 1999. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T-cell tolerance to islet β cells of nonobese diabetic mice. J. Immunol. 163: 743-750.
11. Wheat, W., R. Kupfer, D. G. Gutches, G. R. Rayat, J. Beilke, R. I. Scheinman, and D. R. Wegmann. 2004. Increased NF-κB activity in B-cells and bone marrow-derived dendritic cells from NOD mice. Eur. J. Immunol. 34: 1395-1404.
12. Silveira, P. A., and A. G. Baxter. 2001. The NOD mouse as a model of SLE. Autoimmunity 34: 53-64.
13. Hulbert, C., B. Riseili, M. Rojas, and J. W. Thomas. 2001. B-cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J. Immunol. 167: 5535-5538.
14. Silveira, P. A., J. Dombrowsky, E. Johnson, H. D. Chapman, D. Nemazee, and D. V. Serreze. 2004. B-cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172: 5086-5094.
15. Yang, Y., and P. Santamaria. 2003. Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice. Diabetologia 46: 1447-1464.
16. Serreze, D. V., and E. H. Leiter. 2001. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr. Dir. Autoimmun. 4: 31-67.
17. Johnson, E. A., P. Silveira, H. D. Chapman, E. H. Leiter, and D. V. Serreze. 2001. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes. J. Immunol. 167: 2404-2410.
18. Prochazka, M., D. V. Serreze, W. N. Frankel, and E. H. Leiter. 1992. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41: 98-106.
19. Hill, N. J., P. A. Lyons, N. Armitage, J. A. Todd, L. S. Wicker, and L. B. Peterson. 2000. NOD Idd5 locus controls insulins and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49: 1744-1747.
20. Wicker, L. S., G. Chamberlain, K. Hunter, D. Rainbow, S. Howlett, P. Tiffen, J. Clark, A. Gonzalez-Munoz, A. M. Cumiskey, R. L. Rosa, et al. 2004. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173: 164-173.
21. 2-microglobulin. J. Immunol. 160: 1472-1478.
22. Reifsnyder, P. C., R. Li, P. A. Silveira, G. Churchill, D. V. Serreze, and E. H. Leiter. 2005. Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice. Genes Immun. 6: 528-538.
23. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
24. Silveira, P. A., E. Johnson, H. D. Chapman, T. Bui, R. M. Tisch, and D. V. Serreze. 2002. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32: 3657-3666.
25. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180: 1553-1558.
26. Kendall, P. L., E. J. Woodward, C. Hulbert, and J. W. Thomas. 2004. Peritoneal B-cells govern the outcome of diabetes in non-obese diabetic mice. Eur. J. Immunol. 34: 2387-2395.
27. Noorchashm, H., D. J. Moore, Y. K. Lieu, N. Noorchashm, A. Schlachterman, H. K. Song, C. F. Barker, and A. Naji. 1999. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell. Immunol. 195: 75-79.
28. Li, Y., H. Li, D. Ni, and M. Weigert. 2002. Anti-DNA B-cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med. 196: 1543-1552.
29. 1 mice. Lupus 11: 277-286.
30. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710.
31. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B-cell subsets reveals multiple selection points during peripheral B-cell maturation. J. Immunol. 167: 6834-6840.
32. Langmuir, P. B., M. M. Bridgett, A. L. Bothwell, and I. N. Crispe. 1993. Bone marrow abnormalities in the non-obese diabetic mouse. Int. Immunol. 5: 169-177.
33. Hussain, S., and T. L. Delovitch. 2005. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B-cells is associated with increased T-cell costimulation and the development of insulitis. J. Immunol. 174: 680-687.
34. Hussain, S., K. V. Salojin, and T. L. Delovitch. 2004. Hyperresponsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes. Diabetes 53: 2003-2011.
35. Gagnerault, M. C., J. J. Luan, C. Lotton, and F. Lepault. 2002. Pancreatic lymph nodes are required for priming of β cell reactive T-cells in NOD mice. J. Exp. Med. 196: 369-377.
36. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of isle T-cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189: 331-339.
37. Goodnow, C. C. 1992. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10: 489-518.
38. high B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174: 4821-4827.
39. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B-cells. Annu. Rev. Immunol. 23: 161-196.
40. Acevedo-Suarez, C. A., C. Hulbert, E. J. Woodward, and J. W. Thomas. 2005. Uncoupling of anergy from developmental arrest in anti-insulin B-cells supports the development of autoimmune diabetes. J. Immunol. 174: 827-833.
41. Brodnicki, T. C., K. O'Donnell, F. Quirk, and D. M. Tarlinton. 2006. Congenic nonobese diabetic mouse strains fail to confirm linkage of a marginal zone B lymphocyte phenotype to the Idd11 locus on chromosome 4. J. Immunol. 176: 701-702; author reply 702.
42. Rojas, A., F. Xu, M. Rojas, and J. W. Thomas. 2003. Structure and function of CD72 in the non-obese diabetic (NOD) mouse. Autoimmunity 36: 233-239.
43. Parry, S. L., J. Hasbold, M. Holman, and G. G. Klaus. 1994. Hypercross-linking surface IgM or IgD receptors on mature B-cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152: 2821-2829.
44. Colucci, F., M. L. Bergman, C. Penha-Goncalves, C. M. Cilio, and D. Holmberg. 1997. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. USA 94: 8670-8674.
45. Garchon, H. J., J. J. Luan, L. Eloy, P. Bedossa, and J. F. Bach. 1994. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T-cells to apoptosis induction. Eur. J. Immunol. 24: 380-384.
46. -/- mice display T-cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice. J. Autoimmun. 16: 105-113.
47. Liston, A., S. Lesage, D. H. Gray, L. A. O'Reilly, A. Strasser, A. M. Fahrer, R. L. Boyd, J. Wilson, A. G. Baxter, E. M. Gallo, et al. 2004. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21: 817-830.
48. Bergman, M. L., N. Duarte, S. Campino, M. Lundholm, V. Motta, K. Lejon, C. Penha-Goncalves, and D. Holmberg. 2003. Diabetes protection and restoration of thymocyte apoptosis in NOD Idd6 congenic strains. Diabetes 52: 1677-1682.
49. Seo, S. J., L. Mandik-Nayak, and J. Erikson. 2003. B-cell anergy and systemic lupus erythematosus. Curr. Dir. Autoimmun. 6: 1-20.
50. Rojas, M., C. Hulbert, and J. W. Thomas. 2001. Anergy and not clonal ignorance determines the fate of B-cells that recognize a physiological autoantigen. J. Immunol. 166: 3194-3200.
51. Bonifacio, E., M. Atkinson, G. Eisenbarth, D. Serreze, T. W. Kay, E. Lee-Chan, and B. Singh. 2001. International Workshop on lessons from animal models for human type 1 diabetes: identification of insulin but not glutamic acid decarboxylase or 1A-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50: 2451-2458.